Dr Gretchen M Brophy, PharmD
Critical care — Virginia Commonwealth University, United States
Gretchen M Brophy
LeadR Profile
Critical care
Subspecialties: Neurology - Pharmacy - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 148
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Inflammatory blood-based biomarkers to aid in the assessment and prognostication of traumatic brain injury: a TRACK-TBI study. brain injuries, blood, insemination, artificial, heterologous, brain, biomarkers, brain injuries, traumatic, diagnosis, wounds and injuries | J Neuroinflammation | 2026 | 0 |
| Multicenter comparison of antiplatelet treatment strategies for urgent/emergent neuroendovascular stenting. platelet aggregation inhibitors, stroke, dissection, neuroradiography, arteries, aneurysm, radiography, interventional, therapeutics | Interv Neuroradiol | 2023 | 3 |
| The Evolution of Neurocritical Care Pharmacy: Historical Perspectives and Future Horizons. pharmacists, pharmacy, critical care, research, education | Neurocrit Care | 2025 | 0 |
| Brain injury biomarkers as targets for drugs development and personalized treatment for traumatic brain injury patients. drug development, brain injuries, drug discovery, pharmaceutical preparations, brain, biomarkers, pharmacology, brain injuries, traumatic, research, therapeutics | Front Pharmacol | 2025 | 0 |
| Reversal of Factor Xa Inhibitor-Related Intracranial Hemorrhage: A Multicenter, Retrospective, Observational Study Comparing the Efficacy and Safety of Andexanet and Prothrombin Complex Concentrates. safety, hemorrhage, rivaroxaban, hemostatics, antithrombin iii, intracranial hemorrhages, factor xa inhibitors, factor xa, intensive care units, prothrombin, hemostasis, apixaban | Crit Care Med | 2025 | 3 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Nimodipine Variability in SAH NCT07065903 — hemorrhage, blood, brain, aneurysm, multiple chronic conditions, subarachnoid hemorrhage, nimodipine, pharmacokinetics | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map